Market Views – Page 28 – media

Gates streams $50m into Britain’s Dementia Discovery Fund

British venture the Dementia Discovery Fund (DDF) has received a $50 million investment from Bill Gates, to help fuel progress toward disease-modifying therapies for Alzheimer’s disease.
- Source: Pharmatimes
- 820
- November 14, 2017
Alzheimer's Market Views therapy
Robots and AI Will Take Over These 3 Medical Niches First

We’re no stranger to robotics in the medical field. Robot-assisted surgery is becoming more and more common. Many training programs are starting to include robotic and virtual reality scenarios to provide hands-on training for students without putting patients at risk.
- Source: singularityhub
- 503
- November 13, 2017
Artificial Intelligence Market Views robotics surgery
A Chinese Province Is Sequencing One Million of Its Residents’ Genomes

Authorities in the city of Nanjing, the capital of China’s Jiangsu province, announced at the end of October that they would sequence the genes of 1 million individuals to build a genetic database of Chinese residents. This project is part of the National Health and Medicine Big Data Nanjing Center, a new data storage facility under construction in the region.
- Source: futurism
- 592
- November 10, 2017
cancer chronic gene Market Views sequence
Two years in, the team at NousCom bags $49M to fund first human studies of neoantigen drugs

As NousCom CEO Alfredo Nicosia likes to say, the Basel-based biotech is a relative fledgling at 2-years of age. But the core research team there has been working together for quite a few years.
- Source: Endpts
- 585
- November 9, 2017
immune Market Views oncology vaccine
Mobile Digital health has the potential to save $46 billion a year in health spending

Existing digital health products hold the potential to save the nation $46 billion in healthcare spending if they’re deployed comprehensively, according to a new report from IQVIA, which on Tuesday renamed itself from Quintiles/IMS Health.
- Source: healthcareitnews
- 590
- November 9, 2017
asthma cardiac diabetes healthcare Market Views
Sanofi Taps into Berg’s AI Platform for Developing Better Flu Vaccine

Machine learning technologies have already made huge strides in supporting the efforts of pharmaceutical companies in developing personalized medicines and novel biomarkers. This has been found to be helpful, notably for understanding the efficacy of prophylactic vaccines used for combating infectious diseases.
- Source: researchmoz.us
- 640
- November 8, 2017
Artificial Intelligence Market Views vaccine
Black Death and incurable Marburg Virus now spreading across Africa’s cities

Africa is currently contending with two serious disease outbreaks. The pneumonic plague has been making headlines as it sweeps across Madagascar, but there are concerns about it are being eclipsed by a far more sinister threat: A rare and fatal virus known Marburg virus disease (MVD), which has now broken out in Uganda.
- Source: naturalnews
- 1,128
- November 8, 2017
Market Views MVD pneumonic plague WHO
Moderna Announces New Collaboration with AstraZeneca

Moderna Therapeutics today announced a new license and collaboration with AstraZeneca to co-develop and co-commercialize a messenger RNA (mRNA) therapeutic encoding for Relaxin. The companies will advance the new Relaxin development candidate, AZD7970, toward the clinic as an investigational treatment for heart failure.
- Source: Modernatx
- 465
- November 7, 2017
heart Market Views mRNA
Just two sugary drinks per week may raise type 2 diabetes risk

The World Health Organization (WHO) report that at least 19 million yearly deaths are from cardiometabolic disorders – an umbrella term for cardiovascular disease and conditions such as metabolic syndrome and type 2 diabetes.
- Source: medicalnewstoday
- 590
- November 7, 2017
cardiometabolic diabetes Market Views WHO
Amgen, Novartis Rev Up for New Alzheimer’s Study

Amgen and Basel, Switzerland-based Novartis announced they have expanded their collaboration with the Banner Alzheimer’s Institute (BAI) to launch a new clinical trial in Alzheimer’s.
- Source: Pharmalive
- 682
- November 6, 2017
Alzheimer's API Clinical Trial Market Views

your submission has already been received.

OK

Subscribe

Please enter a valid Email address！

Submit

The most relevant industry news & insight will be sent to you every two weeks.

more

more

Customer Services
Contact Us
Help Center

Buy on Drugdu.com
Browse Product Categories

Free APP

Follow Us

Terms & Conditions | Privacy Policy

粤ICP备16008861号

Copyright © 2016-2018 Drugdu.com. All Rights Reserved.